LFA
WST icon

LGT Financial Advisors’s West Pharmaceutical WST Stock Holding History

LGT Financial Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$219 – 648
2025
Q2 		$219 Buy
+1
New +$214 ﹤0.01% 502
2025
Q1 		– Sell
-154
Closed -$50.4K – 733
2024
Q4 		$50.4K Hold
154
– – 0.11% 145
2024
Q3 		$46.2K Hold
154
– – 0.11% 131
2024
Q2 		$50.7K Hold
154
– – 0.11% 162
2024
Q1 		$60.9K Hold
154
– – 0.07% 211
2023
Q4 		$54.2K Hold
154
– – 0.07% 202
2023
Q3 		$57.8K Buy
+154
New +$59.6K 0.07% 204

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

LGT Financial Advisors's WST Position: Q3 2025 in Review

LGT Financial Advisors sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 1 share — an estimated $219 sold.

LGT Financial Advisors first reported a position in WST in Q3 2023 and held it in 7 quarters. The position peaked at $60.9K in Q1 2024. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • LGT Financial Advisors reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • LGT Financial Advisors sold 1 West Pharmaceutical share in Q3 2025, an estimated $219.
  • LGT Financial Advisors first reported a position in West Pharmaceutical in Q3 2023 and held it in 7 quarters.
  • LGT Financial Advisors's West Pharmaceutical position peaked at $60.9K in Q1 2024.
  • 758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on LGT Financial Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.